Technical Analysis for ZSAN - Zosano Pharma Corporation

Grade Last Price % Change Price Change
grade F 0.975 -3.47% -0.04
ZSAN closed down 3.47 percent on Thursday, June 4, 2020, on 82 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Up
Historical ZSAN trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Calm After Storm Range Contraction -3.47%
Wide Bands Range Expansion -3.47%
Up 3 Days in a Row Strength -3.47%
1,2,3 Pullback Bullish Bullish Swing Setup -2.50%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.50%
Calm After Storm Range Contraction -2.50%
Wide Bands Range Expansion -2.50%
Calm After Storm Range Contraction -0.96%
Inside Day Range Contraction -0.96%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Zosano Pharma Corporation, a clinical stage specialty pharmaceutical company, develops drug formulations for the treatment of various indications. The company delivers formulations through the skin using its proprietary transdermal microneedle patch system. Its lead product candidates comprise Weekly ZP-PTH, a proprietary formulation of parathyroid hormone that has completed a Phase I clinical study for the treatment of severe osteoporosis in women; ZP-Glucagon, a proprietary formulation of glucagon, which has completed a Phase I study for the emergency treatment of severe hypoglycemia; and ZP-Triptan, a proprietary formulation of zolmitriptan that has completed preclinical animal studies for the treatment of migraine. Zosano Pharma Corporation has a strategic partnership and license agreement with Novo Nordisk A/S to develop a microneedle patch product to administer semaglutide for the treatment of type 2 diabetes. The company was founded in 2006 and is headquartered in Fremont, California.
Diabetes Migraine Treatment Of Migraine Stage Specialty Pharmaceutical Emergency Treatment Severe Hypoglycemia Triptans

Is ZSAN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.54
52 Week Low 0.405
Average Volume 1,926,505
200-Day Moving Average 1.33
50-Day Moving Average 0.75
20-Day Moving Average 0.90
10-Day Moving Average 0.96
Average True Range 0.07
ADX 32.22
+DI 30.68
-DI 15.11
Chandelier Exit (Long, 3 ATRs ) 0.87
Chandelier Exit (Short, 3 ATRs ) 0.89
Upper Bollinger Band 1.06
Lower Bollinger Band 0.74
Percent B (%b) 0.74
BandWidth 36.04
MACD Line 0.07
MACD Signal Line 0.07
MACD Histogram 0.0051
Fundamentals Value
Market Cap 38.24 Million
Num Shares 39.2 Million
EPS -1.28
Price-to-Earnings (P/E) Ratio -0.76
Price-to-Sales 0.00
Price-to-Book 1.29
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.08
Resistance 3 (R3) 1.09 1.06 1.06
Resistance 2 (R2) 1.06 1.03 1.05 1.06
Resistance 1 (R1) 1.02 1.02 1.00 1.01 1.05
Pivot Point 0.99 0.99 0.98 0.99 0.99
Support 1 (S1) 0.95 0.96 0.93 0.94 0.90
Support 2 (S2) 0.92 0.95 0.92 0.89
Support 3 (S3) 0.88 0.92 0.89
Support 4 (S4) 0.87